Current Understanding of the Role of PPARγ in Gastrointestinal Cancers

被引:7
|
作者
Zou, Bing [1 ]
Qiao, Liang [1 ,2 ]
Wong, Benjamin C. Y. [1 ]
机构
[1] Univ Hong Kong, Dept Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China
[2] Univ Sydney, Westmead Hosp, Dept Gastroenterol & Hepatol, Storr Liver Unit,Westmead Millennium Inst, Westmead, NSW 2145, Australia
关键词
ACTIVATED-RECEPTOR-GAMMA; INTESTINAL POLYP FORMATION; ALPHA/GAMMA DUAL AGONIST; ABERRANT CRYPT FOCI; COLON-CANCER; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); INHIBITS PROLIFERATION; DEPENDENT SUPPRESSION; LIGAND ROSIGLITAZONE; CELL-PROLIFERATION;
D O I
10.1155/2009/816957
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Numerous studies have indicated that PPAR gamma plays multiple roles such as in inflammation, cell cycle control, cell proliferation, apoptosis, and carcinogenesis, thus PPAR gamma contributes to the homeostasis. Many in vitro studies have showed that ligand-induced activation of PPAR gamma possess antitumor effect in many cancers including CRC. However, the role of PPAR gamma in gastrointestinal cancers, especially in colorectal cancer, is rather controversial. Nevertheless, some recent studies with the positive results on the possible application of PPAR gamma ligands, such as Bezafibrate or Rosiglitazone in gastrointestinal cancers, have suggested a potential usefulness of PPAR gamma agonists in cancer prevention and therapy. In this review, the authors discuss the recent developments in the role of PPAR. in gastrointestinal cancers. Copyright (C) 2009 Bing Zou et al.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Cautious optimism-the current role of immunotherapy in gastrointestinal cancers
    Mendis, S.
    Gill, S.
    CURRENT ONCOLOGY, 2020, 27 : S59 - S68
  • [2] Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
    Li, Jia
    Saif, Muhammad Wasif
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 429 - 441
  • [3] Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives
    Moati, Emilie
    Taly, Valerie
    Garinet, Simon
    Didelot, Audrey
    Taieb, Julien
    Laurent-Puig, Pierre
    Zaanan, Aziz
    CANCERS, 2021, 13 (19)
  • [4] The role of microRNAs in gastrointestinal cancers
    Saito, Yoshimasa
    Suzuki, Hidekazu
    Hibi, Toshifumi
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 : 18 - 22
  • [5] Chemoprevention in gastrointestinal cancers: Current status
    Grau, MV
    Rees, JR
    Baron, JA
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2006, 98 (03) : 281 - 287
  • [6] The Role of Pentraxin 3 in Gastrointestinal Cancers
    Zajkowska, Monika
    Mroczko, Barbara
    CANCERS, 2023, 15 (24)
  • [7] The role of PARP inhibitors in gastrointestinal cancers
    Hanna, Daire
    Chopra, Neha
    Hochhauser, Daniel
    Khan, Khurum
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 171
  • [8] The role of the gut microbiome in gastrointestinal cancers
    Mishra, Yachana
    Ranjan, Abhigyan
    Mishra, Vijay
    Chattaraj, Aditi
    Aljabali, Alaa A. A.
    El-Tanani, Mohamed
    Hromic-Jahjefendic, Altijana
    Uversky, Vladimir N.
    Tambuwala, Murtaza M.
    CELLULAR SIGNALLING, 2024, 115
  • [9] ROLE OF METALLOTHIONEIN EXPRESSION IN GASTROINTESTINAL CANCERS
    Fic, Miroslaw
    Pula, Bartosz
    Rogala, Krzysztof
    Dziegiel, Piotr
    POSTEPY BIOLOGII KOMORKI, 2013, 40 (01) : 5 - 20
  • [10] The Role of Endosonography in the Staging of Gastrointestinal Cancers
    Cho, Jin Woong
    CLINICAL ENDOSCOPY, 2015, 48 (04) : 297 - 301